Activation of the complement system is hampered in type 2 diabetes mellitus, during bacterial infection compared with controls

被引：0
|
作者：
Csuka, Dorottya [1 ]
Barkai, Laszlo [1 ]
Pilely, Katrine [2 ]
Dani, Rahel [3 ]
Dobo, Jozsef [3 ]
Sipter, Emese [1 ]
Prohaszka, Zoltan [1 ]
Gal, Peter [3 ]
Hosszufalusi, Nora [1 ]
Garred, Peter [2 ]
机构：
[1] Semmelweis Univ, Dept Internal Med 3, Budapest, Hungary
[2] Univ Copenhagen, Mol Med Lab, Dept Clin Immunol, Copenhagen, Denmark
[3] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary
来源：
MOLECULAR IMMUNOLOGY | 2018年 / 102卷
关键词：
Type 2 diabetes mellitus; Lectin pathway; Infection; Complement activation;
D O I：
10.1016/j.molimm.2018.06.048
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
033
引用
收藏
页码：141 / 142
页数：2
相关论文
共 50 条
  • [21] Decreased complement factor H is associated with enhanced complement activation and cardiovascular risk in South Asian relatives of patients with type 2 diabetes mellitus
    Richardson, V. R.
    Riyaz, S.
    Standeven, K. F.
    Carter, A. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 871 - 871
  • [22] Type 2 Diabetes Mellitus and Increased Risk for Malaria Infection
    Danquah, Ina
    Bedu-Addo, George
    Mockenhaupt, Frank P.
    EMERGING INFECTIOUS DISEASES, 2010, 16 (10) : 1601 - 1604
  • [23] The Interaction of Helicobacter pylori Infection and Type 2 Diabetes Mellitus
    Hosseininasab Nodoushan, Seyed
    Nabavi, Amin
    ADVANCED BIOMEDICAL RESEARCH, 2019, 8 (01): : 15
  • [24] The membrane attack complex as an indicator of complement hyperactivation in type 2 diabetes mellitus
    Arakelova, E. A.
    Ovsepyan, M. R.
    Boyadzhyan, A. S.
    Arakelyan, A. A.
    Gevorkyan, A. A.
    Mamikonyan, A. A.
    DIABETES MELLITUS, 2011, 14 (03): : 17 - 20
  • [25] Glucose-dependent leukocyte activation in patients with type 2 diabetes mellitus, familial combined hyperlipidemia and healthy controls
    de Vries, Marijke A.
    Alipour, Arash
    Klop, Boudewijn
    van de Geijn, Gert-Jan M.
    Janssen, Hans W.
    Njo, Tjin L.
    van der Meulen, Noelle
    Rietveld, Arie P.
    Liem, Anho H.
    Westerman, Elsbeth M.
    de Herder, Wouter W.
    Cabezas, Manuel Castro
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (02): : 213 - 217
  • [26] The incretin system in the management of type 2 diabetes mellitus
    Stephens, Jeffrey W.
    CLINICAL MEDICINE, 2010, 10 (05) : 491 - 495
  • [27] Hepatitis C virus infection and type 1 and type 2 diabetes mellitus
    Antonelli, Alessandro
    Ferrari, Silvia Martina
    Giuggioli, Dilia
    Di Domenicantonio, Andrea
    Ruffilli, Ilaria
    Corrado, Alda
    Fabiani, Silvia
    Marchi, Santino
    Ferri, Clodoveo
    Ferrannini, Ele
    Fallahi, Poupak
    WORLD JOURNAL OF DIABETES, 2014, 5 (05) : 586 - 600
  • [28] MACULAR PIGMENT OPTICAL DENSITY IS LOWER IN TYPE 2 DIABETES, COMPARED WITH TYPE 1 DIABETES AND NORMAL CONTROLS
    Scanlon, Grainne
    Connell, Paul
    Ratzlaff, Matthew
    Foerg, Brittany
    McCartney, Daniel
    Murphy, Audrey
    O'Connor, Karen
    Loughman, James
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (09): : 1808 - 1816
  • [29] SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls
    Goyal, Alpesh
    Gupta, Yashdeep
    Kalaivani, Mani
    Praveen, Pradeep A.
    Ambekar, Samita
    Tandon, Nikhil
    ENDOCRINE PRACTICE, 2022, 28 (02) : 191 - 198
  • [30] Low incidence of vascular complications in patients with diabetes mellitus associated with liver cirrhosis as compared with type 2 diabetes mellitus
    Fujiwara, F
    Ishii, M
    Taneichi, H
    Miura, M
    Toshihiro, M
    Takebe, N
    Ishida, W
    Kaneko, Y
    Kato, A
    Suzuki, K
    Satoh, J
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 205 (04): : 327 - 334
12345